Katja Conrath
Chief Scientific Officer MRM Health
Seminars
Tuesday 10th November 2026
Advancing Defined Microbial Consortia Mechanisms in STARFISH‑UC Development to Improve Ulcerative Colitis Clinical Outcomes
4:00 pm
- Presenting early clinical data from STARFISH UC trials to validate safety, efficacy signals, and differentiation versus FMT and single-strain therapies
- Demonstrating mechanism of action of rationally designed microbial consortia to drive targeted anti-inflammatory pathways and improve engraftment consistency
- Leveraging translational biomarkers and patient stratification strategies to optimize responder identification and enhance clinical trial design success rates
